Literature DB >> 28370603

The feasibility and acceptability of a population-level antenatal risk factor survey: Cross-sectional pilot study.

Anna Mh Price1,2, Hannah E Bryson1, Fiona Mensah2,3, Lynn Kemp4, Lara Bishop5, Sharon Goldfeld1,2.   

Abstract

AIM: Australian data on the prevalence and distribution of antenatal risk factors are scarce. This study aimed to investigate (i) the feasibility and acceptability of an antenatal risk factor survey collected in public settings and (ii) whether the survey risk factors co-occur with more sensitive risk factors that are privately asked by clinicians.
METHODS: Design and setting: study-designed survey linked with clinician-collected risk factors. PARTICIPANTS: pregnant women attending antenatal clinics at two Victorian hospitals. MEASURES: (i) study-designed survey: young pregnancy, no support, poor/fair/good general health, anxious mood, not finishing high school, no income, long-term illness, living without another adult, not employed, never had a job and proxy poverty measures; (ii) Clinician-collected data: smoking, alcohol/marijuana/drug use, domestic violence, social issues, history of mental health problems and depression symptoms. ANALYSES: (i) feasibility and acceptability were assessed through survey completion. Each item was assessed for whether they discriminated risk; dichotomised into risk versus no risk; with a total count calculated. (ii) Co-occurrence was assessed by examining how the risk factor count agreed with clinician-collected items.
RESULTS: One hundred and sixty-six of 186 (89%) eligible women completed the survey; 139 of 166 (84%) consented to linking clinician-collected data. The high response and zero missing data demonstrated feasibility and acceptability. Of women with linked data, 92 of 139 (66%) had ≥1 survey risk factor and 30 of 139 (22%) had ≥3; 36 of 139 (26%) had at least one co-occurring clinician-collected risk factor.
CONCLUSIONS: This survey provides a simple, rapid approach to gathering antenatal risk data publicly. It may be a helpful addition to clinicians' standard history collection.
© 2017 Paediatrics and Child Health Division (The Royal Australasian College of Physicians).

Entities:  

Keywords:  maternal health services; pregnancy; risk factors; screening; socio-economic factors

Mesh:

Year:  2017        PMID: 28370603     DOI: 10.1111/jpc.13510

Source DB:  PubMed          Journal:  J Paediatr Child Health        ISSN: 1034-4810            Impact factor:   1.954


  5 in total

1.  Patterns of maternal depression, anxiety, and stress symptoms from pregnancy to 5 years postpartum in an Australian cohort experiencing adversity.

Authors:  Hannah Bryson; Susan Perlen; Anna Price; Fiona Mensah; Lisa Gold; Penelope Dakin; Sharon Goldfeld
Journal:  Arch Womens Ment Health       Date:  2021-05-25       Impact factor: 4.405

2.  Variations in sustained home visiting care for mothers and children experiencing adversity.

Authors:  Kie Kanda; Stacy Blythe; Rebekah Grace; Emma Elcombe; Lynn Kemp
Journal:  Public Health Nurs       Date:  2021-12-03       Impact factor: 1.770

3.  Processes for engaging and retaining women who are experiencing adversity in longitudinal health services research.

Authors:  Anna Price; Hannah Bryson; Ashlee Smith; Fiona Mensah; Sharon Goldfeld
Journal:  BMC Health Serv Res       Date:  2019-11-14       Impact factor: 2.655

4.  Identification of families in need of support: Correlates of adverse childhood experiences in the right@home sustained nurse home visiting program.

Authors:  Lynn Kemp; Tracey Bruce; Emma L Elcombe; Fiona Byrne; Sheryl A Scharkie; Susan M Perlen; Sharon R Goldfeld
Journal:  PLoS One       Date:  2022-10-03       Impact factor: 3.752

5.  Quality of delivery of "right@home": Implementation evaluation of an Australian sustained nurse home visiting intervention to improve parenting and the home learning environment.

Authors:  Lynn Kemp; Tracey Bruce; Emma L Elcombe; Teresa Anderson; Graham Vimpani; Anna Price; Charlene Smith; Sharon Goldfeld
Journal:  PLoS One       Date:  2019-05-06       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.